Skip to main content
. Author manuscript; available in PMC: 2009 May 1.
Published in final edited form as: Eur J Nucl Med Mol Imaging. 2007 Dec 22;35(5):1008–1018. doi: 10.1007/s00259-007-0658-0

Fig. 2.

Fig. 2

Characterization of HER2-specific binding. A. Representative results of competition binding assay using SKOV-3 cells (log of concentration of competitor compound versus percent of the maximum specific binding of radiolabeled Affibody molecule). B. Representative results of saturation assay using SKOV-3 cells (concentration of radiolabeled Affibody molecule versus concentration bound: NSB – non-specific binding obtained by saturation of the receptors with 100-fold excess of non-labeled Affibody, TB - total binding, and SB - specific binding).